ASK REDCHAT ANYTHING ABOUT ALDEYRA THERAPEUTICS INC.
Aldeyra Therapeutics Inc. (NASDAQ: ALDX)
Listen to this Section
$1.75
+0.0540
(
+3.18% )
469.3K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Reproxalap (ADX-102)DetailsRare genetic disease, Rare diseases, Allergic conjunctivitis |
Phase 3 |
| ADX-2191 (methotrexate injection (DHFR inhibitor))DetailsEye disease , Retinitis Pigmentosa |
Phase 2/3 |
| ADX-629DetailsSjögren-Larsson Syndrome |
Phase 2 |
| ADX-629DetailsAlcoholic hepatitis, Liver disease |
Phase 2 |
| ADX-629DetailsChronic cough |
Failed |
| ADX-629DetailsIdiopathic Nephrotic Syndrome |
Failed |
| ADX-629DetailsAtopic dermatitis |
Phase 2a |
| ADX-246DetailsAtopic dermatitis, Skin disease/disorder |
Phase 1/2 |
| ADX-248DetailsAge-related macular degeneration, Geographic atrophy |
Phase 1/2 |
| ADX-248DetailsAtopic dermatitis, Skin disease/disorder |
Phase 1 |
| ADX-2191DetailsEye disease , Retinitis Pigmentosa |
Phase 2/3 |
| ADX-2191DetailsEye disease , Proliferative vitreoretinopathy, Rare diseases, Primary Vitreoretinal Lymphoma |
Failed |
Market Data
|
| Open |
$1.75 |
| Previous Close |
$1.70 |
| Volume |
469.3K |
| Market Cap |
$102.55M |
| Day Range |
$1.70 - $1.77 |
| 52 Week Range |
$1.07 - $6.18 |
| Shares Outstanding |
60.32M |
| Change % |
+3.18% |
| Net Change |
▲ 0.0540 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2014 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-2,828,883.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2026-03-20 |
Buy |
70000.00 |
DOUGLAS RICHARD |
| 2026-03-19 |
Buy |
5000.00 |
Alfieri Michael |
| 2025-08-15 |
Buy |
2500.00 |
Alfieri Michael |
| 2024-08-14 |
Sale |
-10834.00 |
Greenberg Bruce |
| 2024-08-14 |
Sale |
-16041.00 |
Machatha Stephen |
| 2024-06-06 |
Sale |
-40282.00 |
Walker Neal |
| 2024-06-06 |
Sale |
-40282.00 |
Miller-Rich Nancy |
| 2024-06-06 |
Sale |
-40282.00 |
Bronstein Ben |
| 2024-06-06 |
Sale |
-40282.00 |
Phillips Gary M. |
| 2024-06-06 |
Sale |
-40282.00 |
DOUGLAS RICHARD |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
14 |
Jul 17, 2025 |